SEC FORM
3
SEC Form 3
FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
OMB APPROVAL |
OMB Number: |
3235-0104 |
Estimated average burden |
hours per response: |
0.5 |
|
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 08/27/2015
|
3. Issuer Name and Ticker or Trading Symbol
STERIS CORP
[ STE ]
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
Director |
|
10% Owner |
X |
Officer (give title below) |
|
Other (specify below) |
Sr. V. P., Isomedix & Life Sci |
|
5. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting Person |
|
Table I - Non-Derivative Securities Beneficially Owned |
1. Title of Security (Instr.
4)
|
2.
Amount of Securities Beneficially Owned (Instr.
4)
|
3. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
4. Nature of Indirect Beneficial Ownership (Instr.
5)
|
Common Shares, No Par Value |
23,951
|
D |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivative Security (Instr.
4)
|
2. Date Exercisable and Expiration Date
(Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr.
4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
6. Nature of Indirect Beneficial Ownership (Instr.
5)
|
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Option to Purchase Common Shares |
|
05/30/2022 |
Common Shares, No Par Value |
2,225 |
29.94 |
D |
|
Option to Purchase Common Shares |
|
05/31/2023 |
Common Shares, No Par Value |
10,120 |
45.34 |
D |
|
Option to Purchase Common Shares |
|
05/30/2024 |
Common Shares, No Par Value |
7,000 |
53.52 |
D |
|
Option to Purchase Common Shares |
|
08/10/2025 |
Common Shares, No Par Value |
8,000 |
67.98 |
D |
|
Explanation of Responses: |
Remarks: |
|
/s/ Julia Kipnis, Authorized Representative under Power of Attorney |
09/02/2015 |
|
** Signature of Reporting Person |
Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* If the form is filed by more than one reporting person,
see
Instruction
5
(b)(v). |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
Securities and Exchange Commission Washington, D.C. 20549
RE: STERIS Corporation
Commission File No. 1-14643
1933 Act and 1934 Act Filings
Authorized Representatives
Gentlemen:
The above Company is the issuer of securities registered under Section 12 of the
Securities Exchange Act of 1934. The person signing below confirms, as of the
date appearing opposite
his/her signature, that each of the "Authorized Representatives" named below is
authorized on his/her
behalf to sign such statements (on Form 3, Form 4, Form 5, Form 144, Schedule
13G, or otherwise)
with respect to securities of the Company (the "Securities"), and to submit to
the Securities and
Exchange Commission such filings (including reports, notices, and other
statements) with respect to
the Securities, as are required by the Securities Act of 1933, as amended, or
the Securities Exchange
Act of 1934 as amended (collectively, the "Acts"). The person so signing also
confirms the authority of
each of the Authorized Representatives to do and perform, on his/her behalf, any
and all acts and things
with respect to the Securities requisite or necessary to assure compliance by
the signing person with
the filing requirements of the Acts. This authority revokes all prior
authorities with respect to the
Securities previously executed by the person signing below including but not
limited to any such
authorities filed with or given to the Commission by the person signing below.
The authority confirmed
herein shall remain in effect as to the person signing below until such time as
the Commission shall
receive from that person a written communication that terminates or modifies the
authority.
Authorized Representatives
Judith A. Hunter
Julia Kipnis
Rebecca A. Nichols
Dennis P. Patton
Ronald E. Snyder
Michael J. Tokich
J. Adam Zangerle
Dated: August 26, 2015 By: _/s/ Daniel A. Carestio____________________
Daniel A. Carestio